|
NGDN expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.6242562850266E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
1.02199999574282E-08 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62447832963153E-12 |
| Stage1-vs-Stage2 |
3.198400E-01 |
| Stage1-vs-Stage3 |
2.913800E-01 |
| Stage1-vs-Stage4 |
2.216300E-02 |
| Stage2-vs-Stage3 |
1.073180E-01 |
| Stage2-vs-Stage4 |
1.635900E-02 |
| Stage3-vs-Stage4 |
1.965990E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
6.13830097861978E-11 |
| Normal-vs-Asian |
2.09929851280322E-11 |
| Caucasian-vs-AfricanAmerican |
9.623600E-01 |
| Caucasian-vs-Asian |
1.961030E-01 |
| AfricanAmerican-vs-Asian |
3.288600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
8.124600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62458935193399E-12 |
| Normal-vs-Age(81-100Yrs) |
2.1756000000428E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.486000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.637200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.366600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.495400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.319800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.282400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.142100E-02 |
| Classical-VS-Follicular |
9.806000E-01 |
| Classical-VS-Other |
4.043600E-01 |
| Classical-VS-Normal |
1.62447832963153E-12 |
| Tall-VS-Follicular |
2.236200E-02 |
| Tall-VS-Other |
1.442190E-01 |
| Tall-VS-Normal |
1.62447832963153E-12 |
| Follicular-VS-Other |
5.636400E-01 |
| Follicular-VS-Normal |
6.09845507426598E-13 |
| Other-VS-Normal |
2.304800E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
1.47659662275146E-14 |
| N0-vs-N1 |
7.108800E-01 |
|
|
